Subject of the article

Authors

Teshaev U.Sh.

Institution

Bukhara State Medical Institute

Abstract

Introduction. Minimally invasive myocardial revascularization (MIRM) is aimed at performing multiple coronary artery bypass grafting (CABG) through left anterolateral mini-thoracotomy, one of the subtypes of which is MICSCAB (Minimally Invasive Cardiac Sur-gery/Coronary Artery Bypass Grafting). Objective: To evaluate the effectiveness and safety of CABG surgery using the MICSCAB meth-od in patients with coronary artery disease with multivessel coronary lesions in a comparative aspect depending on the presence / absence of obesity. Material and methods: Forty-one patients with coronary heart disease and multivessel coronary artery disease were examined. The average age of the patients was 62.8±6.7 years. All subjects were male. All subjects underwent general clinical laboratory and functional studies, as well as coronary angiography (CAG) and CABG-MICSCAB. The presence or absence of obesity was determined by calculating the body mass index (BMI, kg/m2). Results: Patients with obesity, according to the general clinical parameters, were characterized by younger age, more frequent occurrence of tachycardia, but relatively preserved central hemody-namic parameters, despite more complex coronary vessel lesions. Conclusion: The results of CABG using the minimally invasive MICSCAB technique are not in-ferior to those using the traditional CABG technique, and in some respects even surpass it. Our re-sults also contribute to a positive conclusion on the use of this technique, including in patients with an elevated BMI (i.e. with obesity of 1-2 degrees).

Key words

coronary artery bypass grafting (CABG); multiple coronary artery bypass grafting through left anterolateral mini-thoracotomy (MICSCAB); body mass index (BMI); obesity.

Literature

1. Combest S., Hantler C.B. Coronary artery bypass grafting (CABG). In: Bready L.L., Dillman D., Noorily S.H., editors. Decision making in anesthesiology. 4th ed. Philadelphia:Mosby, Inc.; 2007. p. 282-285.
2. McGinn JTJr, et al. Minimally invasive coronary artery bypass grafting: Dual center experience in 450 consecutive patients. Circulation. 2009.
3. Зеньков А.А. Непосредственные и отдаленные результаты многососудистого миниинвазивного коронарного шунтирования без затрагивания аорты: исследование с уравненными группами пациентов. Клиническая и экспериментальная хирургия. Журнал им. акад. Б.В. Петровского. 2018;6(1):10-20.
4. Hannan E, Wu C, Smith CR, Higgins RS, Carlson RE, Culliford AT. Off-pump versus on-pump coronary artery bypass graft surgery: differences in short-term outcomes and in long-term mortality and need for subsequent revascularization. Circulation. 2007;116:1145-1152.
5. Kobayashi J, Tashiro T, Ochi M, et al. Early outcome of a randomized comparison of off-pump and on-pump multiple arterial coronary revascularization. Circulation. 2005;112:I338-1143.
6. Lemma MG, Coscioni E, Tritto FP, et al. On-pump versus offpump coronary artery bypass surgery in high-risk patients: operative results of a prospective randomized trial (on-off study). J Thorac Cardiovasc Surg. 2012;143:625-631.
7. McGinn JT, Shariff MA, Nabagiez JP, et al. Minimally Invasive CABG is Safe and Reproducible: Report on the First Thousand Cases. Presentation at International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS). Boston. 2014.
8. Nambiar P, Kailash S. Coronary artery bypass grafting - is it time to do away with sternotomy? 15 ISMICS Annual Scientific Meeting.Berlin. 2015 3-6 June.
9. Исаев М.Н., Екимов С.С., Чернов И.И., и др. Бимаммарное коронарное шунтирование на работающем сердце через левостороннюю мини-торакотомию. Клиническая и экспериментальная хирургия. Журнал им. акад. Б.В. Петровского. 2016;6(4):27-30.
10. Киладзе И.З., Жбанов И.В., Урюжников В.В., и др. Миниинвазивное множественное коронарное шунтирование через левую миниторакотомию. XXIII Ежегодная Сессия НМИЦ ССХ им. А.Н. Бакулева. М. 2019, 19-21 мая.
11. Юрченко Д.Л., Пайвин А.А., Денисюк Д.О., и др. Многососудистое минимально инвазивное шунтирование коронарных артерий. Грудная и сердечно-сосудистая хирургия. 2015;(6):40-46.
12. Teo KK, Cohen E, Buller C, et al. Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology/ Canadian Society of Cardiac Surgery position statement on revascularization-multivessel coronary artery disease. Can J Cardiol 2014; 30: 1482–1491.
13. Neumann F, Sousa-Uva M and Ahlsson A. ESC/EACTS guidelines on myocardial revascularization. EuroIntervention 2019; 40: 87–165.
14. Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/ AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: Executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2012; 126: 3097–3137.
15. Mohr FW, Morice M-C, Kappetein AP, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 2013; 381: 629–638.
16. Farkouh ME, Domanski M, Dangas GD, et al. Long-term survival following multivessel revascularization in patients with diabetes: the FREEDOM Follow-On Study. J Am Coll Cardiol 2019; 73: 629–638.
17. Giustino G, Serruys PW, Sabik JF, et al. Mortality after repeat revascularization following PCI or CABG for left main disease: the EXCEL trial. JACC Cardiovasc Interv 2020; 13: 375–387.
18. Mäkikallio T, Holm NR, Lindsay M, et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial. Lancet 2016; 388: 2743–2752.
19. Ruel M, Falk V, Farkouh ME, et al. Myocardial revascularization trials. Circulation 2018; 138: 2943–2951.
20. Ruel M. Editorial: coronary artery surgery: a resurgence and new opportunity to serve our patients better. Curr Opin Cardiol 2019; 34: 627.
21. WHO STEPS chronic disease risk factor surveillance. Egypt STEPS survey, 2011–2012. www.who.Int/chp/steps. Fact sheet 6 – 3c – 1.
22. Патология сердечно-сосудистой системы. Часть I. «Важнейшие показатели кровообращения, применяемые для оценки функциональных нарушений сердечно-сосудистой системы.» Учебно-методическая разработка для самостоятельной работы студентов лечебного и педиатрического факультетов. - М., РГМУ, 2014, 28 с.
23. Kolh, P. Guidelines on myocardial revascularization. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI) / P. Kolh, W. Wijns, N. Danchin, C. Di Mario, V. Falk, T. Folliguet [et al.] // Eur J Cardiothorac Surg. – 2010. – Vol. 38 (Suppl). – Р. S1–S52. – doi:10.1093/eurheartj/ehq277.
24. Kieser T. M., Rose S., Kowalewski R., Belenkie I. Transit-time flow predicts outcomes in coronary artery bypass graft patients: a series of 1000 consecutive arterial grafts / // Eur J Cardiothorac Surg. – 2010. – Vol. 38. – Р. 155–162. – doi:10.1016/j.ejcts.2010.01.026.
25. Микуляк А.И. Комплексная интраоперационная оценка коронарных шунтов с помощью метода ультразвуковой доплеровской флоуметрии. // Автореф.дис.Ниж.Н. 2021; 26 с.
26. Smith Jr S. C., Benjamin E. J., Bonow R. O. et al., AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association // Journal of the American College of Cardiology. – 2011. – Vol. 58. – P. 2432–2446.
27. Шальнова С.А. Конради А. О., Карпов Ю. А. Анализ смертности от сердечно-сосудистых заболеваний в 12 регионах Российской Федерации, участвующих в исследовании «Эпидемиология сердечно-сосудистых заболеваний в различных регионах России» // Российский кардиологический журнал. – 2012. – № 5 (97). – С. 6–11.
28. Dorner, T. E. Epidemiology of obesity in Austria // Wiener Medizinische Wochenschrift. – 2016. – March. – Vol. 166. – № 3–4. – P. 79–87. [Epub 2015 Dec 9].
29. Муромцева, Г. А., Концевая А. В., Константинов В. В. и др. Распространенность факторов риска неинфекционных заболеваний в российской популяции в 2012-2013 гг. Результаты исследования ЭССЕ-РФ // Кардиоваскулярная терапия и профилактика. – 2014. – Т. 13. – № 6. – С. 4–11.
30. Hadaegh F., Ghasemi A., Padyab M. et al. // The metabolic syndrome and incident diabetes: assessment of alternative definitions of the metabolic syndrome in an Iranian urban population // Diabetes Research and Clinical Practice. – 2008. – Vol. 80. – № 2. – P. 328–334.
31. Ivanovic B., Tadic M., Bradic Z. et al. // The influence of the metabolic syndrome on atrial fibrillation occurrence and outcome after coronary bypass surgery: A 3-year follow-up study // The Journal of Thoracic and Cardiovascular Surgery. – 2014. – Vol. 62. – № 7. – P. 561–568.
32. Yaginuma K., Kasai T., Miyauchi K. et al. // Propensity score analysis of 10-year long-term outcome after bypass surgery or plain old balloon angioplasty in patients with metabolic syndrome / // The International Heart Journal. – 2011. – Vol. 52. – № 6. – P. 372–376.
33. Yilmaz M. B., Guray U., Guray Y. et al. // Metabolic syndrome negatively impacts early patency of saphenous vein grafts / // Coronary Artery Disease. – 2006. – Vol. 17. – № 1. – P. 41–44.
34. Болотова Н.В., Аверьянов А.П., Лазебникова С.В., Дронова Е.Г. // Гормонально-метаболические нарушения и их коррекция у детей с ожирением // Пробл. эндокр. 2003. - Т. 49, № 4. - С. 22-25.
35. Симаненков В.И., Тихонов С.В., Ильяшевич И.Г., Ледовая А.В., Макиенко В.В., Федорова Н.В. // Эпидемиология, социальные аспекты и патогенез ожирения // Вестник Северо-Западного государственного медицинского университета. - 2017. - T 9. - № 1. - P. 21-27.
36. Глуховский М.Л. Метаболический синдром и аритмии сердца: автореф. дис. … докт. мед. наук. Воронеж, 2012. 48 с.
37. Цыпленкова Н.С., Панова Е.И., Кичигин В.А., Доманова Т.Г. // Связь массы тела с особенностями сердечного ритма у мужчин с артериальной гипертензией. // Вестник Чувашского университета. № 3: 563-567.
38. Watanabe H., et al. Metabolic syndrome and risk of development of atrial fibrillation. The Niigata Preventive Medicine Study. / Watanabe H., Tanabe N., Watanabe T. et al. // Circulation. 2008. Vol. 117. P. 1255-1260.
39. Kokubo Y., et al. Obesity index and the risk of atrial fibrillation in an urban Japanese cohort: The Suita Study Epidemiology and Prevention of CV Disease: Physiology, Pharmacology and Lifestyle. Session Title: Epidemiology of Atrial Fibrillation / Kokubo Y., Shimizu W., Kamakura S.et al. // Circulation. 2011. Vol. 124.
40. Engelman DT, Adams DH, Byrne JG, Aranki SF, Collins JJ Jr, Couper GS, et al. Impact of body mass index and albumin on morbidity and mortality after cardiac surgery. J Thorac Cardiovasc Surg 1999;118:866-73.
41. Maurer MS, Luchsinger JA, Wellner R, Kukuy E, Edwards NM. The effect of body mass index on complications from cardiac surgery in the oldest old. J Am Geriatr Soc 2002;50:988-94.
42. Moulton MJ, Creswell LL, Mackey ME, Cox JL, Rosenbloom M. Obesity is not a risk factor for significant adverse outcomes after cardiac surgery. Circulation 1996;94(9 Suppl):II87-92.
43. Birkmeyer NJ, Charlesworth DC, Hernandez F, Leavitt BJ, Marrin CA, Morton JR, et al. Obesity and risk of adverse outcomes associated with coronary artery bypass surgery. Northern New England Cardiovascular Disease Study Group. Circulation 1998;97:1689-94.
44. Prasad US, Walker WS, Sang CT, Campanella C, Cameron EW. Influence of obesity on the early and long term results of surgery for coronary artery disease. Eur J Cardiothorac Surg 1991;5:67-73.
45. Hong NS, Kim KS, Lee IK. The association between obesity and mortality in the elderly differs by serum concentrations of persistent organic pollutants: a possible explanation for the obesity paradox. Int J Obes (Lond). 2012 Sep; 36(9): 1170–5.
46. Шпагина О.В., Бондаренко И.З. «Парадокс ожирения» – еще один взгляд на проблему сердечно-сосудистых заболеваний. // Ожирение и метаболизм 34’2013:3-9.
47. Habbu A., Lakkis N., Dokainish H. The Obesity Paradox: Fact or Fiction? Am J Cardiol. 2006; 98 (7): 944–948.
48. McGinn J.T., Shariff M.A., Nabagiez J.P. et al. // Minimally Invasive CABG is Safe and Reproducible : Report on the First Thousand Cases // Innov. Tech. Cardiothorac. Vasc. Surg. - 2014. - Vol. 9, № 3. - P. 158.
49. McGinn J.T., Shariff M.A, Lapierre H. et al. Minimally Invasive CABG : Results to 6 years // Circulation. - 2012. - Vol, 126. № 21 Suppl. - P. A18959.
50. Lemma M., Atanasiou T., Contino M. // Minimally invasive cardiac surgery ‒ coronary artery bypass graft [Электронный ресурс] // Multimedia manual of cardiothoracic surgery: MMCTS / European Association for Cardio-Thoracic Surgery. - 2013. - Vol. 2013, №1093. - URL: http://mmcts.oxfordjournals.org/ content/2013/mmt007.long (дата обращения: 01.12.2016).
51. Юрченко Д.Л., Пайвин А.А., Денисюк Д.О. и др. // Многососудистое минимально инвазивное шунтирование коронарных артерий // Грудная и сердечно-сосудистая хирургия. - 2015. - № 6. - С. 40–46.
52. Зеньков А.А., Островский Ю.П. // Непосредственные результаты полной миниинвазивной реваскуляризации миокарда // Новости хирургии. - 2012. - Т. 20, № 5. - С. 11–17.
53. Iso H., Sato S., Kitamura A.et al. // Metabolic syndrome and the risk of ischemic heart disease and stroke among Japanese men and women // Stroke. – 2007. – Vol. 38. – № 6. – P. 1744–1751.